Universal Health Services, Inc. (UHS)
NYSE: UHS · Real-Time Price · USD
219.32
+5.29 (2.47%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Universal Health Services Stock Forecast
Stock Price Forecast
The 12 analysts that cover Universal Health Services stock have a consensus rating of "Buy" and an average price target of $218, which forecasts a -0.60% decrease in the stock price over the next year. The lowest target is $185 and the highest is $263.
Price Target: $218 (-0.60%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Universal Health Services stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 11 | 11 | 9 | 9 | 9 | 7 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 16 | 14 | 14 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $250 → $263 | Buy | Maintains | $250 → $263 | +19.92% | Oct 28, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $219 | Hold | Initiates | $219 | -0.15% | Oct 14, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $210 → $249 | Buy | Maintains | $210 → $249 | +13.53% | Oct 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $227 | Hold | Reiterates | $227 | +3.50% | Oct 7, 2025 |
| Barclays | Barclays | Buy Maintains $259 → $250 | Buy | Maintains | $259 → $250 | +13.99% | Sep 18, 2025 |
Financial Forecast
Revenue This Year
17.39B
from 15.83B
Increased by 9.84%
Revenue Next Year
18.25B
from 17.39B
Increased by 4.97%
EPS This Year
20.84
from 16.82
Increased by 23.88%
EPS Next Year
22.34
from 20.84
Increased by 7.22%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.3B | 19.6B | |||
| Avg | 17.4B | 18.3B | |||
| Low | 16.8B | 17.0B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.9% | 12.6% | |||
| Avg | 9.8% | 5.0% | |||
| Low | 5.9% | -2.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.93 | 24.63 | |||
| Avg | 20.84 | 22.34 | |||
| Low | 19.55 | 19.65 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 36.3% | 18.2% | |||
| Avg | 23.9% | 7.2% | |||
| Low | 16.2% | -5.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.